Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 275 No 7371 p473
15 October 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Payment by Results “poses severe challenges”

Government reforms that will bring a market economy into contracts for hospital work were criticised by the Audit Commission this week.

Payment by Results

· Hospitals are paid for the work they do at nationally agreed prices under Payment by Results

· Under the old system hospitals are paid according to block contracts negotiated locally and not linked to actual work carried out

· The system is expected to encourage PCTs to commission more services in primary care

The new contract system Payment by Results (see Panel right), first introduced in foundation hospital trusts in April 2004, “poses severe challenges for financial management in some trusts and health economies”, said its report “Early lessons from Payment by Results”.

The commission fell short on recommending that plans to extend the system to all NHS trusts next April should be abandoned. But it did warn ministers that the “potential benefits” of the system would only be realised once clinicians understood its implications and there is “significant improvement” to NHS contracting information and financial systems.

Audit Commission chairman James Strachan said: “It is clear that foundation trusts and PCTs have been challenged by the complexities of introducing Payment by Results and it has exposed underlying financial difficulties where they exist. There are real dangers for the NHS in the short term, particularly given the recent increase in the number of organisations and areas with financial problems.”

In a statement Health Secretary Patricia Hewitt said the Government was pushing ahead with its plans to roll out Payment by Results by next April. She said: “Payment by Results is not causing financial problems in the NHS. It is revealing problems in some NHS trusts and helping them to overcome their difficulties. Payment by Results is part of the solution not the problem.”

Back to Top


©The Pharmaceutical Journal